Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTRB1 | P17538 | 5/20 | 0.61 |
| ▸ | CTSC | P53634 | 7/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CTSH | P09668 | 1/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | CTSK | P43235 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | CTSL | P07711 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | ALPI | P09923 | 1/20 | 0.45 |
| ▸ | PKM | P14618 | 1/20 | 0.45 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.45 |
| ▸ | XIAP | P98170 | 1/20 | 0.45 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7316156 | 1.00 | CTRB1 (0.61) | CTRB1CTSCCYP3A4CYP1A2CTSH | |
| SCHEMBL9143156 | 1.00 | CTRB1 (0.61) | CTRB1CTSCCYP3A4CYP1A2CTSH | |
| SCHEMBL27602044 | 1.00 | CTRB1 (0.61) | CTRB1CTSCCYP3A4CYP1A2CTSH | |
| SCHEMBL3710225 | 0.94 | CTRB1 (0.56) | CTRB1CTSCCYP3A4CYP1A2CTSH | |
| SCHEMBL1795838 | 0.90 | CTSL (0.60) | CTRB1CTSKCTSL | |
| SCHEMBL5323913 | 0.88 | CTSC (0.55) | CTRB1CTSCCYP3A4CYP1A2CTSH | |
| SCHEMBL2574907 | 0.86 | CTRB1 (0.50) | CTRB1CTSCNPC1RAB9A | |
| SCHEMBL2574911 | 0.86 | CTRB1 (0.50) | CTRB1CTSCNPC1RAB9A | |
| SCHEMBL583122 | 0.86 | CTSC (0.76) | CTSCCYP3A4CYP1A2CTSHCYP2D6 | |
| SCHEMBL1691349 | 0.86 | CTSC (0.76) | CTSCCYP3A4CYP1A2CTSHCYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0272671-B1 | Aryloxy and arylacyloxy methyl ketones as thiol protease inhibitors | SANDOZ LTD (CH) | 1994-03-16 | — | — | EP | claimed |
| US-5055451-A | Prevent tissue damage | SYNTEX INC. (US) | 1991-10-08 | — | — | US | claimed |
| US-4980343-A | Inhibit colon and rectal tumors | BAYER AKTIENGESELLSCHAFT (DE) | 1990-12-25 | — | — | US | claimed |
| EP-0365956-A2 | Carcinostatic agents | BAYER AG (DE) | 1990-05-02 | — | — | EP | claimed |
| EP-0272671-A2 | Aryloxy and arylacyloxy methyl ketones as thiol protease inhibitors | SANDOZ LTD. (CH) | 1988-06-29 | — | — | EP | claimed |
| US-4314936-A | BY MEASUREM,ENT OF FLUORESENCE | YEDA RESEARCH AND DEVELOPMENT CO., LTD. (IL) | 1982-02-09 | — | — | US | claimed |
| US-5468480-A | Active against N-A-benzoyl-DL-arginine p-nitroanilide | THE BOOTS COMPANY PLC (GB) | 1995-11-21 | — | — | US | disclosed |
| US-5380656-A | Chymopapain and method of purifying it on an inhibitory dipeptide affinity column | THE BOOTS COMPANY PLC (GB) | 1995-01-10 | — | — | US | disclosed |
| EP-0470136-B1 | THERAPEUTIC AGENT | BOOTS CO PLC (GB) | 1994-06-22 | — | — | EP | disclosed |
| EP-0272671-B1 | Aryloxy and arylacyloxy methyl ketones as thiol protease inhibitors | SANDOZ LTD (CH) | 1994-03-16 | — | — | EP | disclosed |
| US-5158936-A | Treating or prevention of tissue damage, inflammation, bone resporpption and muscular dystrophy | SYNTEX (U.S.A.) INC. (US) | 1992-10-27 | — | — | US | disclosed |
| EP-0470136-A1 | THERAPEUTIC AGENT. | BOOTS CO PLC (GB) | 1992-02-12 | — | — | EP | disclosed |
| US-5055451-A | Prevent tissue damage | SYNTEX INC. (US) | 1991-10-08 | — | — | US | disclosed |
| EP-0272671-A2 | Aryloxy and arylacyloxy methyl ketones as thiol protease inhibitors | SANDOZ LTD. (CH) | 1988-06-29 | — | — | EP | disclosed |
| US-4656269-A | RENIN INHIBITORY EFFECT WHEN ADMINISTERING ORALLY; HYPOTENSIVE AGENTS | KISSEI PHARMACEUTICAL CO., LTD. (JP) | 1987-04-07 | — | — | US | disclosed |
| EP-0216539-A2 | Novel amino acid derivatives | Kissei Pharmaceutical Co. Ltd. (JP) | 1987-04-01 | — | — | EP | disclosed |
| EP-0206807-A2 | Novel amino acid derivatives | Kissei Pharmaceutical Co. Ltd. (JP) | 1986-12-30 | — | — | EP | disclosed |
| EP-0200406-A2 | Novel amino acid derivatives | Kissei Pharmaceutical Co. Ltd. (JP) | 1986-11-05 | — | — | EP | disclosed |
| EP-0190891-A2 | Novel amino acid derivatives | Kissei Pharmaceutical Co. Ltd. (JP) | 1986-08-13 | — | — | EP | disclosed |
| US-4314936-A | BY MEASUREM,ENT OF FLUORESENCE | YEDA RESEARCH AND DEVELOPMENT CO., LTD. (IL) | 1982-02-09 | — | — | US | disclosed |